Obsidian Security Launches EMEA CIO Advisory Board and Partnership with NORMA Cyber to Build Upon Accelerating Traction in the EMEA Market
18.10.2022 08:30:00 EEST | Business Wire | Press release
Obsidian Security, the leader in SaaS Security Posture Management (SSPM), announced the formation of its EMEA CIO Advisory Board and partnership with NORMA Cyber, the cybersecurity service provider to the Norwegian maritime industry, the fourth largest in the world. With growing traction in EMEA, we are pleased to announce that Marc van der Heijden will join and lead our CIO Advisory Board. He brings deep industry expertise and valuable insights from his previous roles as the former CTO of Alshaya Group and SVP of Global IT for Adidas. Mr. van der Heijden will help bring on additional board members from his CIO community who collectively will help drive thought leadership and deliver insights to Obsidian and the extended European CIO and CISO community.
“As we continue to gain traction with customers and prospects in Europe, having someone like Marc, who brings an acute understanding of the security challenges of SaaS and has walked in the shoes of our CIO and CISO customers, lead our CIO Advisory Board in EMEA is invaluable,” said Hasan Imam, CEO of Obsidian Security.
“I’ve been in the IT industry for more than 30 years and I see the immediate value that Obsidian brings to the market as SaaS migration continues to accelerate,” said van der Heijden. “From my experience running global IT organizations, I’ll be able to provide thought leadership to Obsidian and my peers as they face the challenges of protecting data in their SaaS environment.”
NORMA Cyber, the company building unified resilience against cyber threats for the Norwegian maritime industry, supporting over 3,400 vessels worldwide, is among the notable list of expanding EMEA-based Obsidian partners. The company is offering Obsidian’s solution to its member vessels to help proactively protect against threats to Microsoft 365, Salesforce, and more so that they can focus on the day-to-day operations of their vessels instead of monitoring security alerts and potential compromises.
“Obsidian is delivering incredible value and insights to our member vessels worldwide, solving many of the security issues our members experience in moving to SaaS,” said Øyvind Berget, Chief Technical Officer at NORMA Cyber. “With data residency high on the agenda in Europe, Obsidian is allowing our 3,400 members the ability to monitor and protect against data governance threats. Seeing these threats across SaaS solutions in a single pane of view is critical to us. Obsidian promises always-on monitoring and protection, and meets the compliance standards that our members need to operate seamlessly.”
Obsidian will be at eCrime & Cybersecurity Mid-year Summit in London tomorrow, October 19, where Chris Fuller, principal product architect will be speaking during a session titled “Cookies and SPAM: Exploring MFA bypass techniques used by attackers to breach SaaS applications.”
About Obsidian Security
Obsidian Security protects the applications businesses rely on most. We are the first and only comprehensive security solution built for SaaS. Our platform helps reduce enterprise risk by proactively identifying SaaS misconfigurations, detecting real-time threats and enabling visibility into risky SaaS integrations. Notable Fortune 500 companies trust Obsidian Security to secure SaaS apps, such as Salesforce, GitHub, ServiceNow, Workday and Atlassian. Headquartered in Southern California, Obsidian Security is a privately held company and is backed by Menlo Ventures, Norwest Venture Partners, Greylock Partners, IVP, GV and Wing. For more information, visit www.obsidiansecurity.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221017006070/en/
Contact information
Jill Creelman
Obsidian@inkhouse.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom